Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Michigan: The Complete Guide for Women, Survivors, and Families
If you are reading this in Michigan, you have likely been through a journey that began with a difficult diagnosis or a decision to improve your life, only to find yourself facing a new and frightening medical crisis. Whether you underwent a post-mastectomy reconstruction at an institution like the Rogel Cancer Center in Ann Arbor, sought elective breast augmentation in a high-volume aesthetic practice in Grand Rapids, or received a mastopexy “internal bra” in Detroit, you may now be experiencing complications that no one told you were possible. You are not alone, and the pain, redness, or swelling you are feeling is not “in your head.” It may be the result of a medical device that was never actually studied or cleared by the FDA specifically for use in breast tissue.
At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we have spent twenty-seven years protecting individuals against powerful institutions. Managing Partner Ralph Manginello and Associate Attorney Lupe Peña understand the terrifying intersection of medical negligence and defective product manufacturing. Our firm possesses the structural litigation experience required to prosecute multi-defendant institutional liability cases—experience evidenced by our current role as lead counsel in Bermudez v. Pi Kappa Phi, a $10,000,000 litigation in Harris County that resulted in the shutdown of an entire institutional chapter. We bring that same aggressive, data-driven advocacy to the women of Michigan who have been injured by defective surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds.
Why You Need Answers Now
The medical device industry has operated for years under a regulatory shortcut known as the 510(k) clearance pathway. This allows manufacturers to bring products like GalaFLEX, Phasix, and AlloDerm to the market without the rigorous clinical trials typically associated with life-altering implants. Consequently, women across Michigan have had materials placed in their bodies that were originally designed for hernia repair or general soft-tissue reinforcement—not the delicate and immunocompromised environment of the breast.
If your reconstruction has failed, if you have been diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), or if you are suffering from persistent “Red Breast Syndrome,” the clock is ticking. Under Michigan law, the window to file a claim is finite. We are here to help you secure the records, preserve the evidence, and fight for the compensation you need to pay for revision surgeries and the lifelong care you deserve.
When you are ready to talk through what happened to you, we are here to listen. Call 1-888-ATTY-911 for a confidential, no-cost consultation. There is no obligation, and you pay nothing unless we recover for you.
Defining the Defective Devices: Mesh, ADM, and Scaffolds
For many Michigan patients, the surgery was described simply as a “mesh-assisted” procedure. However, the materials used fall into three distinct categories, each with its own risk profile and manufacturer liability.
Acellular Dermal Matrix (ADM)
ADM is a biologic tissue graft derived from human or animal skin. The cells are stripped away, leaving a collagen scaffold meant to support the implant or tissue expander. Leading brands include AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), and Strattice. While surgeons often tell patients ADM is “natural,” these products can carry bacterial endotoxins. Even after sterilization, these endotoxins can trigger a sterile inflammatory response known as Red Breast Syndrome, causing intense redness and pain that often mimics a severe infection.
Bioabsorbable and Resorbable Scaffolds
These are synthetic, dissolvable scaffolds designed to provide support for a period—typically 12 to 24 months—before being absorbed by the body. The most common is GalaFLEX, made by Galatea Surgical and now owned by Becton Dickinson (BD). GalaFLEX is often used in “internal bra” procedures. The crisis for Michigan women arises when these scaffolds do not dissolve as promised or when they degrade prematurely, leading to “bottoming out,” permanent deformity, or chronic neuropathic pain.
Synthetic Surgical Mesh
Standard synthetic mesh, often made of polypropylene, is sometimes used off-label in breast surgery. These products are essentially the same materials used in the disastrous transvaginal mesh and hernia mesh litigations. They are prone to erosion, migration, and permanent integration into the chest wall, making removal nearly impossible without catastrophic tissue loss.
The Regulatory Failure: 510(k) “Predicate Creep” and the Michigan Patient
One of the most shocking facts for Michigan patients is that the FDA has never determined the safety and effectiveness of surgical mesh specifically for breast surgery. In a November 9, 2023, letter to health care providers, the FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
How, then, did these devices end up in Michigan operating rooms? The answer is the 510(k) clearance pathway (21 USC §360c). Rather than proving a device is safe through new clinical trials (the PMA pathway), manufacturers only have to show the device is “substantially equivalent” to a “predicate” device already on the market.
This leads to a phenomenon we call “predicate creep.” For example, the GalaFLEX mesh used in internal bra procedures today can trace its regulatory lineage back to a surgical suture. A suture is not a mesh, and the forces it faces in a breast are not the same. By claiming equivalence to a series of older, unrelated products, manufacturers bypass the safety testing that would have revealed these high complication rates. As your Michigan counsel, Ralph Manginello and Lupe Peña use this regulatory history to overcome preemption defenses and hold manufacturers accountable for their failure to warn.
The Spectrum of Injury: When Reconstruction Fails
We represent women across Michigan, from the Detroit metro area to the Upper Peninsula, who are dealing with the physical and emotional fallout of device failure.
BIA-ALCL: The Implant Cancer Risk
Breast Implant-Associated Anaplastic Large Cell Lymphoma is a distinct T-cell lymphoma (non-Hodgkin) recognized by the World Health Organization. It is not breast cancer; it is a cancer of the immune system found in the scar tissue (capsule) around the implant. Pathology reports for BIA-ALCL must be scrutinized for CD30-positive and ALK-negative biomarkers. If you have felt a late-onset swelling or lump years after your reconstruction at a facility like Beaumont Health or the Karmanos Cancer Institute, this diagnosis must be ruled out immediately.
Red Breast Syndrome and Endotoxin Science
Red Breast Syndrome is a specific sterile inflammation caused by ADM. Peer-reviewed literature indicates this is often an endotoxin-mediated event. Even when the device is “sterile” by regulatory standards, the bacterial remnants (lipopolysaccharides) can trigger a host response. Patients often undergo multiple rounds of unnecessary IV antibiotics because Michigan doctors mistake this for a standard infection, only to find the redness only resolves when the ADM is explanted.
Surgical Complications and Disfigurement
- Skin-flap Necrosis: The death of the tissue overlying the reconstruction, often leading to total loss of the implant.
- Mesh Extrusion: The device physically poking through the skin.
- Capsular Contracture: Baker Grade III or IV hardening of the breast that causes severe, permanent pain.
- Failed Nipple Reconstruction: The loss of the NAC due to poor blood supply caused by the bulk of the ADM or scaffold.
Your injury is not a “side effect”—it is a failure of the device. If you are facing any of these issues, call Attorney911 at 1-888-288-9911 for help.
Active Litigation and the Whistleblower Record
Michigan patients deserve to know they are fighting a battle that is already being waged in federal courts.
Allergan BIOCELL MDL 2921
There is a massive multidistrict litigation (MDL 2921) currently pending before Judge Brian R. Martinotti in the District of New Jersey. This MDL addresses the textured implants, like the Allergan BIOCELL products recalled in 2019. The first surgical-explant bellwether trial is currently scheduled for October 19, 2026. This trial will set the pace for settlements for thousands of women, including many in Michigan.
The Dr. Hooman Noorchashm Whistleblower Allegations
The case against Becton Dickinson (BD), the manufacturer of GalaFLEX and Phasix, is bolstered by the record of whistleblower Dr. Hooman Noorchashm. A former Medical Director at BD, Dr. Noorchashm was terminated in 2022 after raising alarms about surgical mesh safety. His allegations, filed in public record, include claims that breast cancer recurrences in BD’s GalaFLEX trials were withheld from the FDA and that the manufacturer engaged in aggressive off-label marketing to Michigan surgeons who were never told of the risks.
Legal Rights for the Michigan Patient
Michigan law presents a unique landscape for product liability. Your case requires an attorney who understands the specific hurdles of Michigan Statutes.
Statute of Limitations in Michigan
Under Michigan Compiled Laws § 600.5805, the general statute of limitations for personal injury is three years. However, in medical device cases, the “Discovery Rule” is critical. If your mesh was implanted five years ago but the FDA only issued its warning letter in late 2023, your three-year clock may only have started when you became aware (or should have become aware) of the connection between your injury and the device. Ralph Manginello and our team carefully analyze your medical records to push the discovery date as far as the law allows, ensuring you aren’t barred from seeking justice.
No Fee Unless We Recover
We represent Michigan clients on a contingency fee basis. This is especially important for women who have already been financially devastated by medical bills and lost wages. You do not pay us for our time or expenses upfront. We only get paid if we win your case via settlement or jury verdict.
Bilingual Representation: Hablamos Español
In Michigan’s diverse communities—from Southwest Detroit to the Hispanic populations in Grand Rapids and Holland—language should never be a barrier to justice. Associate Attorney Lupe Peña is a third-generation Texan who provides full client consultations in fluent Spanish. This ensures that the technical details of your surgery and the legal nuances of your case are never lost in translation.
Lupe Peña y nuestro equipo estamos aquí para ayudar a las familias de Michigan. Si prefiere hablar en español, llámenos hoy mismo al 1-888-ATTY-911.
Evidence Preservation: What Michigan Patients Must Do
If you believe your mesh or scaffold is failing, the actions you take today will determine the outcome of your lawsuit tomorrow.
- Request Your Operative Reports: Hospital records in Michigan belong to you. You must secure the “Operative Note” and the “Device Implant Log.” Look for the Unique Device Identifier (UDI) stickers. These stickers contain the lot number and brand of your mesh.
- Save the Device (Explant Protocol): If you are having the mesh or scaffold removed, it is considered toxic evidence. You must instruct your surgeon—in writing—that the explanted device is to be preserved and not discarded or sent back to the manufacturer for “analysis.” The manufacturer’s analysis is almost always used to hide evidence of a defect.
- Secure Pathology Slides: If tissue was removed due to BIA-ALCL or chronic inflammation, the pathology slides are vital. We help our Michigan clients secure these slides for independent review by experts specialized in device-associated lymphomas.
- Document the Pain: Keep a log of your symptoms, the redness, and the dates of any drainage procedures. Photographs of the affected area can be powerful evidence of the inflammation common in Red Breast Syndrome.
Why The Manginello Law Firm?
When you look for a Michigan defective breast mesh attorney, you will find many generalist personal injury firms. They handle car accidents, dog bites, and slips and falls. They may not know the difference between the 510(k) and PMA pathways. They likely haven’t read the most recent Case Management Orders in the Allergan MDL.
At Attorney911, the difference is substantive command. Ralph Manginello’s twenty-seven years of experience include admission to the United States District Court for the Southern District of Texas and a continuous record of handling complex, high-stakes institutional liability cases. Our firm’s ratings—including an Avvo “Excellent” 8.2 and a 5.0 of 5.0 five-star review profile—reflect our dedication to our clients.
We don’t just file papers; we build narratives based on the science the manufacturers tried to hide. We know that behind every case is a woman in cities like Lansing, Flint, or Kalamazoo who has been robbed of her peace of mind and her physical health.
Frequently Asked Questions for Michigan Plaintiffs
Is surgical mesh approved by the FDA for breast surgery?
No. The FDA has cleared these products for general soft-tissue reinforcement, but it has not determined they are safe or effective for use in the breast. Any use of surgical mesh in breast reconstruction or augmentation is considered “off-label.”
What if my mesh was implanted more than three years ago?
Michigan’s three-year statute of limitations typically runs from the date you discovered or should have discovered the injury. If you only recently found out your complications were caused by the mesh—perhaps after seeing an FDA safety communication—you may still have a valid claim.
How do I find out which brand of mesh was used?
You must obtain your hospital’s “Implant Log.” This document contains the stickers with the brand name (like GalaFLEX or Strattice) and the lot number. If the hospital is being difficult, we can assist in making a formal legal request for these records.
Can I sue if I was never diagnosed with cancer?
Absolutely. While BIA-ALCL is the most severe outcome, thousands of women suffer from Red Breast Syndrome, capsular contracture, and reconstruction failure. These “non-cancer” injuries are eligible for significant compensation for medical costs, pain and suffering, and disfigurement.
Will I have to travel to Texas to work with your firm?
No. While our principal office is in Texas, we represent clients in federal courts across the country. We use technology to make the process as easy as possible for our Michigan clients. You can participate in your case from the comfort of your home in Ann Arbor or Detroit.
Damages: What You Can Recover in Michigan
A successful product liability claim against a mesh manufacturer can recover:
- Past and Future Medical Expenses: This includes the cost of the original surgery, the revision or explant surgery, and any future reconstructive procedures like an autologous DIEP flap or TRAM flap.
- Lost Wages: Time missed from work for surgeries and recovery.
- Physical Pain and Suffering: Compensation for the chronic pain and systemic illness caused by the device.
- Permanent Disfigurement: Michigan recognizes the profound psychological impact of losing one’s breast or suffering permanent scarring.
- Loss of Consortium: Your spouse may be entitled to damages for the impact your injury has had on your relationship.
Michigan’s non-economic damages caps (MCL § 600.1483) are complex, especially in the context of product liability versus medical malpractice. We help you categorize your damages to maximize your recovery within the Michigan legal framework.
A Message for Our Michigan Community
The manufacturers of these devices—Allergan, Becton Dickinson, C.R. Bard—had billions of dollars in revenue while Michigan women were being used as a massive, unauthorized clinical trial. Ralph Manginello and Lupe Peña are here to say that it stops now. You deserve to be represented by a firm that has walked this path before, a firm that knows how to pierce corporate shields and institutional defenses.
Whether you are seeking a second opinion or you are ready to file your claim, we are standing by. We serve all 83 counties in Michigan, ensuring every woman from the lakefront to the inner city has access to elite-tier legal representation.
You have been through enough. Let us handle the legal battle while you focus on your healing. Call Attorney911 at 1-888-ATTY-911 or visit us online to schedule your free consultation today.
Resources for Michigan Patients
- Rogel Cancer Center (Ann Arbor): (800) 865-1125
- Karmanos Cancer Institute (Detroit): (800) 527-6266
- Susan G. Komen Breast Care Helpline: (877) 465-6636
- Living Beyond Breast Cancer: (855) 807-6386
- Attorney911 Main Intake Line: 1-888-ATTY-911
This content is for educational purposes and does not constitute medical or legal advice. Every case is unique. Contact The Manginello Law Firm, PLLC for a free consultation regarding the specific facts of your situation in Michigan.
